Related Experiment Video
Updated: Oct 22, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
A Comparative Study on Virology, Epidemiology, and Clinical Features of SARS and COVID-19
Yanmei Zhao1, Qianying Lu1, Xiangyan Meng1
1Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the COVID-19 pandemic. This study compares SARS-CoV-2 with SARS-CoV, detailing their virology, epidemiology, and clinical features for better epidemic control.
Area of Science:
- Virology
- Epidemiology
- Clinical Medicine
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, emerged in late 2019.
- SARS-CoV-2 is a novel zoonotic coronavirus related to SARS-CoV.
- By October 2021, COVID-19 resulted in over 246 million infections and nearly 5 million deaths globally.
Purpose of the Study:
- To compare the virology, epidemiology, and clinical features of SARS-CoV and SARS-CoV-2.
- To identify commonalities and differences between the two coronaviruses.
- To inform strategies for monitoring and controlling future coronavirus epidemics.
Main Methods:
- Comparative analysis of scientific literature.
- Review of virological data.
- Examination of epidemiological trends and clinical case studies.
Main Results:
- Detailed comparison of SARS-CoV and SARS-CoV-2 characteristics.
- Highlighting distinct properties in viral shedding, transmission, and disease progression.
- Identification of shared pathogenic mechanisms and host responses.
Conclusions:
- Understanding the distinct and common properties of SARS-CoV and SARS-CoV-2 is crucial.
- This comparative knowledge aids in developing effective surveillance and intervention strategies.
- Preparedness for future highly pathogenic human coronavirus outbreaks is enhanced.
Abstract:
In December 2019, an outbreak of an unknown cause of pneumonia (later named coronavirus disease 2019 [COVID-19]) occurred in Wuhan, China. This was found to be attributed to a novel coronavirus of zoonotic origin, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously named 2019 novel coronavirus or 2019-nCoV). The SARS-CoV-2, a new type of highly pathogenic human coronavirus related to severe acute respiratory syndrome coronavirus (SARS-CoV), spread rapidly worldwide and caused 246,303,023 confirmed infections, including 4,994,160 deaths, by October 31, 2021. SARS-CoV-2 and SARS-CoV vary in their specific characteristics, regarding epidemics and pathogenesis. This article focuses on the comparison of the virology, epidemiology, and clinical features of SARS-CoV and SARS-CoV-2 to reveal their common and distinct properties, to provide an up-to-date resource for the development of advanced systems and strategies to monitor and control future epidemics of highly pathogenic human coronaviruses.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Viral Mutations
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

